SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-04-141590
Filing Date
2004-08-16
Accepted
2004-08-16 14:22:15
Documents
6
Period of Report
2004-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 360637
2 LARRY ROMEL EMPLOYEE OFFER LETTER dex101.htm EX-10.1 24531
3 CERT. OF PRINCIPAL EXECUTIVE OFFICER RULE 13A-14(A) dex311.htm EX-31.1 8337
4 CERT. OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER RULE 13A-14(A) dex312.htm EX-31.2 8351
5 CERT. OF PRINCIPAL EXECUTIVE OFFICER 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 3643
6 CERT. OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 3654
  Complete submission text file 0001193125-04-141590.txt   411295
Mailing Address
Business Address 1124 COLUMBIA STREET SUITE 130 SEATTLE WA 98104 2062626200
XCYTE THERAPIES INC (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 04977854
SIC: 2834 Pharmaceutical Preparations